GLUE 6.93 (+6.45%)
US61225M1027BiotechnologyBiotechnology

Monte Rosa Therapeutics (GLUE) Stock Highlights

6.93 | +6.45%
2024-12-21 05:18:19
Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the bodys natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates.

Statistics

Range Today
6.41 7.14
Volume Today 2.63M
Range 1 Year
3.21 12.4
Volume 1 Year 207.42M
Range 3 Year
2.44 22.16
Volume 3 Year 314.3M
Range 10 Year
2.44 45.56
Volume 10 Year 343.33M

Highlights

Market Capitalization 568.9M (small)
Floating Shares 38.14M
Current Price 6.93
Price To Earnings -4.55
Price To Revenue 62.87
Price To Book 2.59
Earnings Per Share -2.16
Payout Ratio 0%

Performance

Latest +6.45%
1 Month -15.9%
3 Months +12.32%
6 Months +96.87%
1 Year +24.64%
3 Years -61.65%
5 Years -68.5%
10 Years -68.5%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.